According to a recent LinkedIn post from Artera, the company is slated to participate in a ViVE 2026 session alongside Hanger, Inc.’s VP of Patient & Employee Experience, Carrie Davis. The post describes a discussion focused on moving from general interest in artificial intelligence to deploying AI agents for patient access.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post highlights that Hanger is portrayed as a collaborator with Artera in implementing AI agents intended to transform aspects of the care experience. For investors, this positioning may signal that Artera is deepening relationships with healthcare providers and showcasing real-world AI use cases, which could support future commercial traction.
By emphasizing “unique AI strategies” and agent deployment in a high-visibility conference setting, the post suggests Artera is aiming to align itself with leading-edge health tech innovation. Participation in ViVE’s Data Innovation Theater may enhance brand visibility among decision-makers and could contribute to pipeline development, though the post does not disclose specific contracts, revenue figures, or financial targets.
For the broader industry, the focus on AI agents for patient access underscores ongoing digitization trends in patient engagement and operational efficiency. If Artera can convert this thought-leadership presence into scalable deployments with partners like Hanger, it could strengthen its competitive position in the healthcare AI and patient-communication segments over the medium term.